All single peptides purchased includes 3ml Bacteriostatic h20

Retatrutide

What it is:

Retatrutide is an experimental peptide drug for obesity and metabolic disease.

Mechanism:

Retatrutide is a triple hormone receptor agonist, meaning it activates three metabolic hormone pathways:

• Glucagon-like peptide-1 receptor → increases satiety, slows gastric emptying

• Glucose-dependent insulinotropic polypeptide receptor → improves insulin response and metabolism

• Glucagon receptor → increases energy expenditure and fat burning

Potential effects studied:

• Significant weight loss

• Reduced appetite

• Improved blood sugar control

• Increased energy expenditure

Research results (clinical trials):

• In a Phase 2 obesity trial, participants lost up to ~24% body weight in 48 weeks, which is among the largest reductions seen in obesity medications.

Research status:

• Currently in Phase 3 clinical trials for obesity and metabolic diseases

• Not yet approved for general medical use.